维普中文期刊产品整合服务
6篇 您的检索式:作者名="HAWLE H"
    题名 作者 年代 出处 被引量
1Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘PEREYL PAR IDAENS R HAWLE H 2007Ann Oncoi2007,18,64:1
2Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2007Ann Oncol2007,18,1:1
3Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2007Ann Oncol2007,,18:1
4Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘PEREY L PARIDAENS R HAWLE H 2007Ann Oncol2007,18,:1
5Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2006Ann Oncol2006,10,:1
6Clinical benefit of fulvcs- trant in postmcnopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘Percy L Paridaens R Hawle H 2007Ann Oncol2007,18,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费